BIMC
NVO

Benson Investment Management Company’s Novo Nordisk NVO Stock Holding History

Benson Investment Management Company’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-65,019
Closed -$4.51M – 58
2025
Q1 		$4.51M Buy
+65,019
New +$5.37M 1.97% 27
2024
Q3 		– Sell
-41,521
Closed -$5.93M – 60
2024
Q2 		$5.93M Sell
41,521
-60
-0.1% -$7.95K 2.45% 10
2024
Q1 		$5.34M Sell
41,581
-2,525
-6% -$301K 2.27% 13
2023
Q4 		$4.56M Buy
+44,106
New +$4.36M 2.33% 19

Other funds holding NVO

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Benson Investment Management Company's NVO Position: Q2 2025 in Review

Benson Investment Management Company sold out of Novo Nordisk (NVO) in Q2 2025, closing a stake of 65,019 shares — an estimated $4.51M sold.

Benson Investment Management Company first reported a position in NVO in Q4 2023 and held it in 4 quarters. The position peaked at $5.93M in Q2 2024. 1,482 funds tracked by Wall St. Rank hold NVO as of Q2 2025.

  • Benson Investment Management Company reported no remaining Novo Nordisk position as of Q2 2025 after selling out during the quarter.
  • Benson Investment Management Company sold 65,019 Novo Nordisk shares in Q2 2025, an estimated $4.51M.
  • Benson Investment Management Company first reported a position in Novo Nordisk in Q4 2023 and held it in 4 quarters.
  • Benson Investment Management Company's Novo Nordisk position peaked at $5.93M in Q2 2024.
  • 1,482 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2025.

Based on Benson Investment Management Company's 13F filing for Q2 2025, filed 24 Jul 2025.